This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Saladax Biomedical Inc., Other. Active years: 2016-2020.
Location History:
- Doylestown, PA (US) (2016 - 2020)
- Princeton, NJ (US) (2020)
Company Filing History:
2 out of 28 
1 out of 834,411 Years Active: 2016-2020
Title: The Innovations of Paul Rhyne
Introduction
Paul Rhyne is an accomplished inventor based in Doylestown, PA (US). He holds a total of 3 patents that reflect his significant contributions to the field of immunoassay standards and clinical biomarkers. His work has advanced the methodologies used in analyzing critical health indicators.
Latest Patents
Rhyne's latest patents include innovative approaches to immunoassay standards and the measurement of tau using intra-assay calibration standards. The first patent provides novel peptides, compositions, and methods for creating quantitative standards to calibrate analytes. These innovations enable the development of standards and calibrators for analyzing clinical biomarkers, such as Tau. Additionally, kits comprising these peptides or compositions are designed for use in assays, including sandwich immunoassays. His second patent also focuses on creating quantitative standards for calibrating analytes and measuring clinical biomarkers, further enhancing the accuracy of immunoassays.
Career Highlights
Throughout his career, Paul Rhyne has worked with notable companies, including Saladax Biomedical Inc. His expertise in the field has allowed him to make significant advancements in the development of clinical diagnostic tools.
Collaborations
Rhyne has collaborated with professionals such as Flora Berisha and Robert John Neely, contributing to the success of various projects in the biomedical field.
Conclusion
Paul Rhyne's innovative work in immunoassay standards and clinical biomarkers has made a lasting impact on the field of diagnostics. His patents and collaborations continue to influence advancements in medical technology.